AMNEAL PHARMACEUTICALS, INC. Distribution Made to Limited Partner, Cash Distributions Declared
AMNEAL PHARMACEUTICALS, INC. (AMRX) reported Distribution Made to Limited Partner, Cash Distributions Declared of $191.56 million for the 4-month period ending 2018-05-03, per its 10-Q filed 2019-08-05.
Discontinued › Notes › Equity
us-gaap:DistributionMadeToLimitedPartnerCashDistributionsDeclared · last filed 2019-08-05
- AMNEAL PHARMACEUTICALS, INC. distribution made to limited partner, cash distributions declared for the quarter ending 2018-03-31 was $38.56M.
- AMNEAL PHARMACEUTICALS, INC. distribution made to limited partner, cash distributions declared for fiscal 2017 was $375.26M, a 87.06% increase from fiscal 2016.
- AMNEAL PHARMACEUTICALS, INC. distribution made to limited partner, cash distributions declared for fiscal 2016 was $200.62M.
| Period end | Distribution Made to Limited Partner, Cash Distributions Declared 1 month | Distribution Made to Limited Partner, Cash Distributions Declared 3 month | Distribution Made to Limited Partner, Cash Distributions Declared 4 month | Distribution Made to Limited Partner, Cash Distributions Declared 12 month |
|---|---|---|---|---|
| 2018-05-03 | $153.00M 10-Q · filed 2019-08-05 | $191.56M 10-Q · filed 2019-08-05 | ||
| 2018-03-31 | $38.56M 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | $375.26M 10-K · filed 2019-03-01 | |||
| 2016-12-31 | $200.62M 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |